The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes.
about
Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activityHere today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazinesBeyond THC: The New Generation of Cannabinoid Designer DrugsSynthetic cannabinoids 2015: An update for pediatricians in clinical practiceGone to Pot - A Review of the Association between Cannabis and PsychosisSpice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoidsDesigner drugs 2015: assessment and management.A survey of synthetic cannabinoid consumption by current cannabis users."Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans.Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDP-glucuronosyltransferasesNovel Drugs of Abuse: A Snapshot of an Evolving Marketplace.Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects.Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS.Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urineSevere toxicity following synthetic cannabinoid ingestion.Convulsions associated with the use of a synthetic cannabinoid product.First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201.Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugsAKI associated with synthetic cannabinoids: a case series.A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.CP47,497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonistsK2 toxicity: fatal case of psychiatric complications following AM2201 exposure.College students and use of K2: an emerging drug of abuse in young personsSolid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine.A survey study to characterize use of Spice products (synthetic cannabinoids).Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeysAcute intoxication caused by a synthetic cannabinoid in two adolescents.Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific maInhalation exposure to smoke from synthetic "marijuana" produces potent cannabimimetic effects in miceHuman metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.Spicing things up: synthetic cannabinoids.Fascination and Social Togetherness-Discussions about Spice Smoking on a Swedish Internet Forum.Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis.Effects and risks associated with novel psychoactive substances: mislabeling and sale as bath salts, spice, and research chemicals.
P2860
Q21135310-05BAB229-15C8-40D5-8A0B-BAD8E379D60AQ24631675-F8AE3CF2-323A-468F-8087-73986D40EB54Q24635230-E5A40FC3-DC41-4997-BB4A-FDA8CB6D7039Q26767016-19174BF3-5C97-4676-8D04-AF4CEA6BA17CQ26865311-0C80C7C4-5862-4035-9C96-D507DD763C24Q27010555-7F80B472-2108-4617-995F-D15424034FDEQ30300017-F1D24B83-7765-4797-896E-2C2C745F5B04Q30408913-7AD1ED1C-1A92-4010-A78E-0718C6B774FFQ30455650-D8E57039-0C04-411E-9E25-34BD114D6254Q33160231-F54F923C-3D6F-46E8-B2AC-E514688CD694Q33725088-C1059A32-4B47-40FC-BF67-7406006F3FB5Q33906178-E8DE672B-1A42-4D93-9D89-E3DCF8E68141Q34098379-0B5C360A-E73E-4FD4-8B8D-D99C560484BCQ34142699-0DF0D100-2EE4-454E-B82F-0E73C6950E68Q34173626-0CF569E4-6247-43AC-9CA8-2761F9932D70Q34179558-3F813066-68EA-47F0-B02B-09E116B36D66Q34194731-09D3BBBD-A4D7-486E-8513-D93345290F12Q34240070-00CDAA3E-6910-4C5A-82A5-6D465C6D7196Q34296844-4C8D8941-6105-420E-AD12-F054445590FAQ34314602-A98EFCA3-23E6-4CC2-9D96-FDA02A06444AQ34317945-C0770317-A590-40B4-821B-7A2B22EE8A9BQ34501742-10AD5C5F-522C-4B01-B7F7-AB6188E1A00CQ34617484-1B8A8AF7-51B1-465E-8C20-818777DD7020Q34981205-C21D6746-908E-40FD-BCDC-80DA41DB430AQ35057032-8515A77D-EB66-4EA2-BFC2-78B51B7DFD94Q35123941-0B5A1BBB-7F24-491B-A81B-842FBE4406F3Q35164115-54A82630-CB89-4901-A6B3-093FC432976CQ35552364-CC583E0B-C7DE-439A-AC9F-3F3DC106BD22Q35785005-8CB58011-4CF7-45BD-9CA4-4A633D96AA9EQ36174226-5D84E2AF-529C-440D-9A4D-299DBD633A27Q36314660-3523839A-4921-4C91-A54E-DA2ACBCB35D7Q36335446-ACC65161-175A-44F2-84D5-1E018FC26CD0Q36385137-DFA512C8-FF1F-4B26-9B75-FE226C54669EQ36409544-9C2E7C04-30AF-4B94-A30F-BD535AB92E58Q36938493-57DBFF22-4468-409A-9EA4-6694C18DEE55Q36953261-503ED2A1-80A4-4F80-B476-D8D4C3DCF7D3Q37237996-FC540E8C-25CE-42F8-8209-3F4032759A98Q37373130-E1F4E410-4482-48A3-AA77-5FF5F1CC2692Q37637031-EE4E6115-05AB-4BB0-824A-701C667E61B5Q37663461-4EB211B9-398C-40BB-ACBB-13D42CA5483F
P2860
The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
The synthetic cannabinoid Spic ...... recurrent psychotic episodes.
@en
The synthetic cannabinoid Spic ...... recurrent psychotic episodes.
@nl
type
label
The synthetic cannabinoid Spic ...... recurrent psychotic episodes.
@en
The synthetic cannabinoid Spic ...... recurrent psychotic episodes.
@nl
prefLabel
The synthetic cannabinoid Spic ...... recurrent psychotic episodes.
@en
The synthetic cannabinoid Spic ...... recurrent psychotic episodes.
@nl
P2093
P1476
The synthetic cannabinoid Spic ...... recurrent psychotic episodes.
@en
P2093
Hagen B Huttner
Helge Müller
Juan-Manuel Maler
Martin Köhrmann
Wolfgang Sperling
P304
P356
10.1016/J.SCHRES.2009.12.001
P407
P577
2010-01-08T00:00:00Z